Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Operating income | -$829K | -$3.30M | -$172K |
| Net income | -$1.73M | -$3.26M | -$207K |
| EPS (diluted) | -$0.02 | -$0.11 | — |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$70.3K | -$66.8K | -$206K |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $0.00 | $0.00 | $0.00 |
| Total assets | $0.00 | $0.00 | $0.00 |
| Total liabilities | $500K | $574K | $631K |
| Shareholders' equity | -$500K | -$574K | -$631K |
| Retained earnings | -$26.1M | -$29.4M | -$29.6M |
| Shares (wtd avg diluted) | 256K | 29.3M | 44.3M |
Every figure is extracted from LataMed AI Corp.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.